Viewing Study NCT05959304


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-25 @ 5:33 PM
Study NCT ID: NCT05959304
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-07-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module